REG OF NITRIC OXIDE PRODUCT IN THE HEPATIC CIRCULATION
REG OF NITRIC OXIDE PRODUCT IN THE HEPATIC CIRCULATION
批准号:
6380058
负责人:
VIJAY H. SHAH
金额:
$12.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2003-06-30
中文摘要
一氧化氮(NO)在肝脏的调节中起重要作用。
血管扩张剂口气。肝内血管收缩有助于
肝硬变时门脉压力升高的发展。这个
这种血管收缩的来源似乎是
肝窦内皮细胞(SEC),一种独特的微血管细胞
在肝窦中排列阻力血管,并表达NO
合酶(NOS)III.剪切力是一种生理生物力学力
已经发现它通过调节局部血流
血管内皮细胞产生血管扩张物质的调节
作为不是。初步研究表明,剪切力激活了一个
酪氨酸磷酸化级联并另外引起亚细胞
一氧化氮合酶(NOS)III的重新分布--两个新事件
一氧化氮合酶的调控机制III.其长期目标
研究旨在阐明NO产生的调节机制
通过剪切力作用于肝脏微循环,并研究它们是如何
可能导致肝硬变的血流动力学改变。
了解调节门脉压力的机制至关重要,因为
门静脉高压症的发展是最重要的单一因素
决定哪些患者将发展为肝硬变的因素
并发症。确定调节一氧化氮的机制
SEC的生产可能导致治疗选择,从而不再有活性
可能受到药物或基因的调节,使患者受益
伴有肝硬变和门脉高压。
英文摘要
Nitric oxide (NO) plays an important role in the regulation of hepatic
vasodilator tone. Intrahepatic vasoconstriction contributes to the
development of an increase in portal pressure in hepatic cirrhosis. The
source of this vasoconstriction appears to be an alteration in the
sinusoidal endothelial cell (SEC), a unique microvascular cell which
lines the resistance vessels in the hepatic sinusoids and expresses NO
synthase (NOS) III. Shear stress is a physiologic biomechanical force
which has been found to modulate regional blood flow through the
regulation of endothelial cell production of vasodilator substances such
as NO. Preliminary studies suggest that shear stress activates a
tyrosine phosphorylation cascade and additionally causes a subcellular
redistribution of NO synthase (NOS) III, two events which are novel
mechanisms of regulation of NOS III. The long term objective of these
studies is to elucidate the mechanisms of regulation of NO production
in the hepatic microcirculation by shear stress and to examine how they
may contribute to the hemodynamic alterations seen in cirrhosis.
Understanding the mechanisms that regulate portal pressure is vital as
the development of portal hypertension is the single most important
factor that determines which patients with cirrhosis will develop
complications. Defining the mechanisms that regulate nitric oxide
production in SEC may lead to therapeutic options whereby NO activity
may be pharmacologically or genetically modulated and benefit patients
with cirrhosis and portal hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of Liver Fibrosis
-
批准号:10407227
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:10612941
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10487453
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10310667
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
-
批准号:10700154
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2021
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:10459414
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:10202402
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:10205237
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:9791141
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic Hepatitis
-
批准号:10449219
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Assessment of Alcoholic Hepatitis with Multiparametric Magnetic Resonance Elastography
-
批准号:9791139
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2018
-
负责人:VIJAY H. SHAH
-
依托单位:
Targeting matrix stiffness in lung and liver fibrosis
-
批准号:9165025
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2016
-
负责人:VIJAY H. SHAH
-
依托单位:
Targeting matrix stiffness in lung and liver fibrosis
-
批准号:9332421
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2016
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8706608
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2013
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8693889
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:9524876
-
项目类别:
-
资助金额:$62.5万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:10152468
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:9056498
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
Molecular Mechanisms of Liver Fibrosis
-
批准号:8466909
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
TREAT-Mayo
-
批准号:8546293
-
项目类别:
-
资助金额:$52.2万
-
财政年份:2012
-
负责人:VIJAY H. SHAH
-
依托单位:
海外基金